News &amp; Updates

Edoxaban affords greater treatment safety than warfarin, while delivering comparable efficacy, in patients with atrial fibrillation (AF), irrespective of diabetes, a recent study has found.

High-dose edoxaban as effective as, but safer than, warfarin for atrial fibrillation

Repaglinide, acarbose effective for postprandial glycaemic control in type 2 diabetes

Both acarbose and repaglinide are effective for the control of postprandial hyperglycaemia in type 2 diabetes patients, a new study has found.

Repaglinide, acarbose effective for postprandial glycaemic control in type 2 diabetes

Upping step count could reduce T2D, hypertension risk

27 Mar 2020 by

A study presented at the recent EPI Scientific Sessions showed that increasing step count could reduce the risk of developing type 2 diabetes (T2D) and hypertension.

Upping step count could reduce T2D, hypertension risk

27 Mar 2020

T2D remission maintained with RYGB vs gastrectomy

26 Mar 2020 by

Real-world data from the PCORnet* Bariatric Study suggest that Roux-en-Y gastric bypass (RYGB) may be preferable to sleeve gastrectomy (SG) in inducing and maintaining type 2 diabetes (T2DM) remission.

T2D remission maintained with RYGB vs gastrectomy

SGLT2 inhibitor–GLP-1 agonist combo improves outcomes in patients with T2DM or obesity

Use of combination therapy with sodium–glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for treating type 2 diabetes mellitus (T2DM) or obese patients yields favourable effects on glycaemic control, body weight and systolic blood pressure (SBP) without increasing the incidence of adverse events, according to the results of a meta-analysis.

SGLT2 inhibitor–GLP-1 agonist combo improves outcomes in patients with T2DM or obesity

Dietary n-3 polyunsaturated fatty acids modify link between irisin and glucose metabolism

Dietary intake of n-3 polyunsaturated fatty acids (PUFA) during pregnancy appears to facilitate the relationship between plasma irisin and glucose metabolism, a new study has found.

Dietary n-3 polyunsaturated fatty acids modify link between irisin and glucose metabolism

Metformin potentially cardioprotective in nondiabetic adults

25 Mar 2020 by

Treatment with metformin yields reductions in total and low-density lipoprotein cholesterol levels in individuals without diabetes, even providing an additional triglyceride-lowering effect among those with polycystic ovary syndrome (PCOS), according to the results of a meta-analysis.

Metformin potentially cardioprotective in nondiabetic adults

25 Mar 2020

Diabetes mellitus ups arrhythmia recurrence after catheter ablation

Catheter ablation of atrial fibrillation (AF) appears to be safe for patients with diabetes mellitus (DM), a recent study has found. However, DM increases the rate of relapse of atrial arrhythmia, particularly in those with persistent AF.

Diabetes mellitus ups arrhythmia recurrence after catheter ablation

Dapagliflozin boosts erythropoiesis, curbs hepcidin

A new study has found that dapagliflozin therapy increases erythropoiesis and haematocrit by suppressing hepcidin and modulating other iron regulatory proteins.

Dapagliflozin boosts erythropoiesis, curbs hepcidin

Infrequent zoledronate therapy prevents bone loss in older women

Infrequent administration of zoledronate 5 mg at a 5.5-year interval has been shown to inhibit bone loss over 11 years, according to a study.

Infrequent zoledronate therapy prevents bone loss in older women